https://www.selleckchem.com/products/tas-120.html
Because of treatment resistance, he died 6 months after PTLD onset. Although he received no long-term administration of immunosuppressive agents, he received long-term dasatinib treatment, which suggests that prolonged dasatinib use after CBT caused EBV reactivation and led to PTLD. Our case suggests that the potential contribution of molecular-targeted agents after HSCT to the development of PTLD should be carefully considered.The TP53 tumor suppressor is the most frequently mutated gene in human cancer. p53 suppresses tumorigenesis by